A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma von Chari, Ajai, Cho, Hearn J., Parekh, Samir, Dhadiwal, Amishi, Garcia, Katarzyna, Belostotsky, Natalie, Catamero, Donna, Brion, Arlynn, Cardone, Lauren, Escalaon, Juliet, Verina, Daniel, Yum, Moon-hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar

Volltext